Lack of immunogenicity of incobotulinumtoxinA in pediatrics: A pooled analysis
Objective: To present pooled data analyses of the immunogenicity of incobotulinumtoxinA (INCO) in pediatrics. Background: BotulinumtoxinA (BoNT-A) is used to treat several chronic pediatric conditions,…A second level neuropsychological battery for Parkinson’s Disease. Normative data from the Italian population.
Objective: The main purpose of this work is to propose modern Italian co-normed data for a battery of ten widely used neuropsychological tests for Parkinsons’…The cortical thickness signature and future phenoconversion in isolated REM-sleep behavior disorder: a longitudinal analysis
Objective: To develop an imaging biomarker predicting subtype-specific phenoconversion in isolated REM sleep behavior disorder (iRBD), we aim at identifying MRI-driven cortical thickness signature in…NODDI- based maps as potential marker for Parkinson’s Disease.
Objective: To assess the predictive power of Diffusion Kurtosis Imaging (DKI) parameters obtained from Neurite orientation dispersion and density imaging tool (NODDI) to differentiate between…Impact of foslevodopa/foscarbidopa on key clinical and patient-reported outcomes in patients with aPD: Responder analysis of two Phase 3 clinical trials
Objective: To evaluate the effect of foslevodopa/foscarbidopa (LDP/CDP, ABBV-951) on clinical and patient-reported outcomes in advanced Parkinson’s disease (aPD) patients using minimal clinically important difference…Intrafamilial phenotypic variability of spastic paraplegia type 7: A Case Report
Objective: To characterize the phenotypic variability of spastic paraplegia type 7 in a single family. Background: Spastic paraplegia type 7 (SPG7) is an autosomal recessive…Efficacy And Safety Of Unilateral MRgFUS Thalamotomy In Patients With Essential Tremor
Objective: To report a single-institution experience of MRI guided high intensity focused ultrasound (MRgFUS) unilateral ventral intermediate nucleus (VIM) thalamotomy in patients with Essential tremor…Cognitive profiling in a cohort of Huntington’s disease (HD) patients
Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy
Objective: Objective: PSP patients typically show reduced amplitude and velocity of vertical saccades, but saccadic abnormalities have also been reported in PD. We investigated the…Case report: Parkinsonim with dyskinesia secondary to amyloid angiopathy
Objective: To report a case of parkinsonism secondary to amyloid angiopathy and discuss the pathophysiology and treatment of this entity. Background: Cerebral amyloid angiopathy is…
- « Previous Page
- 1
- …
- 140
- 141
- 142
- 143
- 144
- …
- 153
- Next Page »